The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dudley Robert Michael since 2022.
This trader's CIK number is 1854161.
At the time of last reporting, Dudley Robert Michael was the Chief Executive Officer of Transcode Therapeutics, Inc.. (stock ticker symbol RNAZ).
Also see all insider trading activities at Transcode Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | RNAZ | 135,607 | $151,090 | 0 | $0 | 0 | $0 |
| 2022 | RNAZ | 50,000 | $78,372 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-09-28 | RNAZ | Buy | 98,000 | .51 | 49,980 |
| 2023-06-20 | RNAZ | Buy | 6,607 | 2.55 | 16,847 |
| 2023-06-21 | RNAZ | Buy | 12,000 | 2.65 | 31,824 |
| 2023-06-09 | RNAZ | Buy | 19,000 | 2.76 | 52,439 |
| 2022-09-14 | RNAZ | Buy | 20,000 | 1.15 | 23,000 |
| 2022-05-31 | RNAZ | Buy | 2,000 | 1.87 | 3,740 |
| 2022-05-27 | RNAZ | Buy | 28,000 | 1.84 | 51,632 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dudley Robert Michael (Chief Executive Officer of Transcode Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.